Plasma sRAGE is not associated with urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage

Standards of Medical Care in Diabetes—2009

Diabetes Care · 2008 · 2.2K citations · Full text

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

Hideto Yonekura, Yasuhiko Yamamoto, Shigeru Sakurai et al. · Biochemical Journal · 2003 · 700 citations · Full text

Vascular Disease, Glycobiology, Immunology +19

Expression of Advanced Glycation End Products and Their Cellular Receptor RAGE in Diabetic Nephropathy and Nondiabetic Renal Disease

Nozomu Tanji, Glen S. Markowitz, Caifeng Fu et al. · Journal of the American Society of Nephrology · 2000 · 476 citations

Purification and Characterization of Mouse Soluble Receptor for Advanced Glycation End Products (sRAGE)

Lana E. Hanford, Jan J. Enghild, Zuzana Valnickova et al. · Journal of Biological Chemistry · 2004 · 216 citations · Full text

Engineering, Glycobiology, Immunology +18

Modulation of Soluble Receptor for Advanced Glycation End Products by Angiotensin-Converting Enzyme-1 Inhibition in Diabetic Nephropathy

Josephine M. Forbes, Suzanne R. Thorpe, Vicki Thallas‐Bonke et al. · Journal of the American Society of Nephrology · 2005 · 211 citations

Hypertension, Glycobiology, Immunology +21